Pedicled medial femoral condyle corticoperiosteal flap for achieving union in patients with nonunion of the distal half of the femur (A short case series of three patients)

带蒂内侧股骨髁皮质骨膜瓣移植术治疗股骨远端半骨不连(三例患者的小病例系列研究)

阅读:1

Abstract

BACKGROUND: Recalcitrant bone nonunion is characterized by impaired biological potential at the fracture site due to diminished vascularity and loss of osteogenic cells, reducing the success rate of nonvascularized bone grafts. In cases of ununited fractures of the tibia and femur with minimal gapping, the medial femoral condyle (MFC) corticoperiosteal flap offers a promising solution. This study aims to evaluate the effectiveness of the pedicled MFC corticoperiosteal flap in achieving union in recalcitrant nonunion of the distal half of the femur. The secondary objective is to report complications associated with this technique. METHODS: Three male patients with recalcitrant nonunion of the distal half of the femur were included. The transposition ratio was calculated by dividing the distance between the medial femoral epicondyle and the nonunion site (DMEB) by the distance from the medial femoral epicondyle to the apex of the lesser trochanter (DMELT). Patients with a ratio greater than 0.5 were excluded. Each patient underwent adequate rigid fixation, followed by harvesting a pedicled MFC corticoperiosteal flap from the medial distal femur. The flap was rotated to cover the nonunion site and augmented with an iliac crest bone graft to fill residual gaps. Bony union was monitored through monthly X-rays and CT scans. RESULTS: All three patients (average age 36.7 years) had recalcitrant nonunion, two cases being aseptic atrophic and one septic. Union was achieved in all patients (100% union rate), with an average time to union of 6.7 months. No mechanical failures were observed. Complications included saphenous nerve injury and seroma in one patient, and an incisional hernia at the iliac crest graft donor site in another. CONCLUSION: The pedicled MFC-CP flap appears to be a feasible option for treating recalcitrant distal femur nonunion, with minimal donor site morbidity. However, larger studies are needed to confirm its efficacy.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。